TREVISAN, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 11.743
AS - Asia 7.636
EU - Europa 5.155
SA - Sud America 1.309
Continente sconosciuto - Info sul continente non disponibili 698
AF - Africa 188
OC - Oceania 23
Totale 26.752
Nazione #
US - Stati Uniti d'America 10.961
SG - Singapore 2.763
IT - Italia 1.694
HK - Hong Kong 1.338
CN - Cina 1.199
BR - Brasile 962
VN - Vietnam 961
RU - Federazione Russa 925
CA - Canada 613
DE - Germania 517
IE - Irlanda 499
SE - Svezia 400
BD - Bangladesh 263
FR - Francia 249
IN - India 234
GB - Regno Unito 200
FI - Finlandia 178
ID - Indonesia 147
AR - Argentina 131
KR - Corea 97
IQ - Iraq 92
UA - Ucraina 85
NL - Olanda 81
TR - Turchia 79
PK - Pakistan 65
JP - Giappone 63
PH - Filippine 59
ES - Italia 57
SA - Arabia Saudita 54
ZA - Sudafrica 53
MX - Messico 51
EC - Ecuador 48
VE - Venezuela 48
AT - Austria 47
CO - Colombia 39
MA - Marocco 33
DK - Danimarca 32
PL - Polonia 32
CR - Costa Rica 30
JM - Giamaica 30
MY - Malesia 26
TN - Tunisia 26
BE - Belgio 23
CL - Cile 23
UZ - Uzbekistan 23
CH - Svizzera 20
TH - Thailandia 20
PE - Perù 19
AU - Australia 18
EG - Egitto 18
NP - Nepal 18
PY - Paraguay 18
CZ - Repubblica Ceca 17
IL - Israele 17
AE - Emirati Arabi Uniti 15
UY - Uruguay 13
JO - Giordania 12
HN - Honduras 11
IR - Iran 11
KE - Kenya 11
DZ - Algeria 10
EE - Estonia 10
ET - Etiopia 10
GR - Grecia 10
GT - Guatemala 9
LT - Lituania 9
OM - Oman 9
LB - Libano 8
PS - Palestinian Territory 8
TW - Taiwan 8
AZ - Azerbaigian 7
BG - Bulgaria 7
BO - Bolivia 7
HR - Croazia 7
HU - Ungheria 7
KG - Kirghizistan 7
NI - Nicaragua 7
PA - Panama 7
RS - Serbia 7
DO - Repubblica Dominicana 6
NO - Norvegia 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
BH - Bahrain 5
NG - Nigeria 5
QA - Qatar 5
TT - Trinidad e Tobago 5
AL - Albania 4
BB - Barbados 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
RO - Romania 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
CM - Camerun 3
CY - Cipro 3
EU - Europa 3
KW - Kuwait 3
MN - Mongolia 3
Totale 26.012
Città #
Singapore 1.573
Hong Kong 1.310
Ashburn 1.225
San Jose 927
Ann Arbor 670
Toronto 511
Dublin 485
Milan 471
Chandler 404
Fairfield 387
New York 360
Ho Chi Minh City 317
Frankfurt am Main 308
Chicago 304
Santa Clara 277
Council Bluffs 276
Los Angeles 255
Princeton 229
Beijing 228
Hanoi 224
The Dalles 213
Houston 200
Rome 192
Hefei 181
Wilmington 179
Woodbridge 176
Dallas 172
Seattle 171
Lauterbourg 149
Helsinki 122
Cambridge 119
Lawrence 108
Jakarta 106
Altamura 99
Seoul 81
São Paulo 80
Moscow 76
Buffalo 68
Shanghai 67
Nuremberg 58
Boardman 53
Columbus 48
Tokyo 48
Munich 47
Phoenix 47
San Diego 47
London 43
Jacksonville 42
Rio de Janeiro 41
Brooklyn 40
Salt Lake City 40
Atlanta 39
Baghdad 39
Da Nang 36
Haiphong 33
Philadelphia 33
Tukwila 33
Chennai 32
Figino 32
Orem 31
Dhaka 29
Montreal 28
Tampa 28
Guangzhou 27
Lappeenranta 27
Belo Horizonte 26
San Francisco 26
Washington 26
Naples 25
Andover 24
Miami 24
Riyadh 24
Stockholm 24
Curitiba 23
Florence 23
Mumbai 23
Turin 23
Turku 23
Brussels 22
Elk Grove Village 22
Boston 21
Brasília 21
Charlotte 21
Dearborn 20
Jeddah 20
Lahore 20
Memphis 20
Nanjing 20
Warsaw 20
Palermo 19
Tashkent 19
Istanbul 18
Kingston 18
San José 18
Amsterdam 17
Bergamo 17
Caracas 17
Johannesburg 17
Biên Hòa 16
Bologna 16
Totale 15.034
Nome #
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched Italian multicenter study. 429
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events: A randomized controlled trial 398
Postprandial hyperglycemia is associated with an increase of blood pressure in type 1 diabetic patients treated with continuous subcutaneous insulin infusion 370
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial 329
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 322
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale] 321
Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study 311
Effects of a low glycemic index high in fiber diet on blood glucose in women with gestational diabetes 303
Independent association of estimated pulse-wave velocity with all-cause mortality in individuals with type 2 diabetes 299
Increased prevalence of autoimmune thyroid disease after COVID-19: A single-center, prospective study 295
Kidney function in acromegaly: evidence from a long-term observational study 292
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 285
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients 276
Continuous subcutaneous insulin infusion in Italy: Third national survey 273
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 271
Open questions on basal insulin therapy in T2D: a Delphi consensus 255
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study 252
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19 249
Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue 245
Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems 241
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 239
Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study 238
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial 234
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes 226
Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy 223
Independent association of history of diabetic foot with all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 222
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial 212
Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 212
Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality 210
Telemedicine home-based management in patients with chronic heart failure and diabetes type II: study protocol for a randomized controlled trial 207
Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors 205
Dapagliflozin and cardiovascular outcomes in type 2 diabetes 203
Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies 197
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study 195
Pre-gestational diabetes during the COVID-19 pandemic in Bergamo, Italy 195
Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus 194
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial 194
Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study 193
The Hyperfiltering Kidney in Diabetes 189
Blood pressure and metabolic effects of acetyl-L-carnitine in type 2 diabetes: DIABASI randomized controlled trial 188
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial 187
Preventing microalbuminuria in type 2 diabetes 184
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 184
Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment 183
Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control 182
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus 182
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 180
A holistic approach to managing cardio-kidney metabolic syndrome: insights and recommendations from the Italian perspective 180
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study 180
Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and covid-19: A multicenter case-control retrospective observational study 178
Does denosumab exert a protective effect against COVID-19? Results of a large cohort study 177
"Insulin autoimmune syndrome": Two very different cases [“Insulin autoimmune syndrome”: Due casi molto diversi] 177
Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes 175
Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 173
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus 172
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines 172
Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy 169
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study 168
La malattia renale e le sue complicanze: percorso per una diagnosi precoce e gestione multidisciplinare 166
Maternal glycaemic levels are associated with incidence of large for gestational age neonates in type 1 diabetic women in pregnancy 165
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study 165
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial 165
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study 164
Gestione multidisciplinare del paziente con sindrome coronarica acuta e diabete mellito: Dalla terapia antitrombotica al trattamento dell'iperglicemia 163
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 163
Resilience in pregnant women with pre-gestational diabetes during COVID-19 pandemic: the experience of the Papa Giovanni XXIII Hospital in Bergamo, Italy 163
Lipids and renal disease 162
Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: Findings from an administrative database 162
Enhanced effects of insulin and angiotensin II on intracellular pH and free cytosolic calcium in fibroblasts from microalbuminuric patients with non-insulin-dependent diabetes mellitus 162
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin 160
Readily Available Index of Insulin Sensitivity Is Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes 158
Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 158
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus 156
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus 156
Efficacy of pasireotide in controlling severe hypercortisolism until cardiac transplantation 153
Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial 153
Once-weekly administration of insulin in the real-world management of type 2 diabetes. A Delphi-like consensus 152
Impact of a complement factor H gene variant on renal dysfunction, cardiovascular events and response to ACE inhibitor therapy in type 2 diabetes 152
Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes 152
Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 151
Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study 151
Relationship between degree of risk factor control and all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 150
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis 150
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease 149
Treatment of diabetes in patients with kidney disease 147
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial 147
Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial 147
The high hourly overnight variability of insulin requirements as an explanation for the superiority of automated insulin delivery systems 147
Diabetes mellitus in critical jobs [Diabete mellito in attività lavorative critiche] 146
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes 145
Association between age at diagnosis and all-cause mortality in type 2 diabetes: the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study 144
Independent correlates of urinary albumin excretion within the normoalbuminuric range in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 144
Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group 140
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes 139
Atrial natriuretic factor in hypertensive and normotensive insulin-dependent diabetics 136
Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012 135
Reply to "Liver fibrosis assessed by transient elastography and albuminuria" 135
Islamic fasting: cardiovascular disease perspective 132
Off-Patent Generic Medicines vs. Off-Patent Brand Medicines for Six Reference Drugs: A Retrospective Claims Data Study from Five Local Healthcare Units in the Lombardy Region of Italy 131
Glycated haemoglobin does not accurately predict average capillary glucose in non insulin-treated type 2 diabetes: The PRISMA study experience 130
Totale 19.741
Categoria #
all - tutte 106.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.835


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022928 0 0 0 67 23 42 60 58 41 256 73 308
2022/20231.926 217 589 154 104 165 327 5 84 114 45 64 58
2023/20241.789 53 48 63 68 264 416 302 61 252 43 22 197
2024/20254.762 249 483 171 193 449 222 198 136 745 717 462 737
2025/202611.616 1.113 886 623 999 1.110 587 1.777 586 840 828 1.216 1.051
2026/20273.356 534 759 1.526 537 0 0 0 0 0 0 0 0
Totale 26.752